Seeing Is Believing

Currently out of the existing stock ratings of Anupam Rama, 442 are a BUY (80.36%), 83 are a HOLD (15.09%), 25 are a SELL (4.55%).
Analyst Anupam Rama, currently employed at JPMORGAN, carries an average stock price target met ratio of 50.84% that have a potential upside of 46.76% achieved within 308 days.
Anupam Rama’s has documented 1,061 price targets and ratings displayed on 72 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on CTMX, CytomX Therapeutics.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for VERA (VERA THERAPEUTICS) at 1/22/2024. The price target of $25 was fulfilled within 3 days with a profit of $8.7 (53.37%) receiving and performance score of 177.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jan-2024
$35
$6.73 (23.81%)
$37
6 days ago
(06-Nov-2026)
13/16 (81.25%)
$6.73 (23.81%)
93
Buy Since 31-Mar-2026
$50
$21.73 (76.87%)
$46
1 months 22 days ago
(21-Sep-2026)
3/5 (60%)
$16.05 (47.28%)
72
Hold Since 01-Dec-2022
$34
$5.73 (20.27%)
$31
3 months 5 days ago
(07-Aug-2026)
11/12 (91.67%)
$1.73 (5.36%)
113
Buy Since 05-Mar-2026
$52
$23.73 (83.94%)
$46
3 months 12 days ago
(31-Jul-2026)
1/3 (33.33%)
$21.98 (73.22%)
215
Buy Since 24-Feb-2025
$55
$26.73 (94.55%)
$52
3 months 13 days ago
(30-Jul-2026)
0/11 (0%)
$22.25 (67.94%)
Which stock is Anupam Rama most bullish on?
Which stock is Anupam Rama most reserved on?
What Year was the first public recommendation made by Anupam Rama?